Valley National Advisers’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.25K Sell
123
-957
-89% -$52K ﹤0.01% 711
2026
Q1
$67K Buy
1,080
+125
+13% +$10K 0.01% 372
2025
Q4
$90K Sell
955
-116
-11% -$11.4K 0.01% 326
2025
Q3
$103K Sell
1,071
-186
-15% -$19.3K 0.02% 294
2025
Q2
$134K Buy
1,257
+260
+26% +$26.3K 0.02% 277
2025
Q1
$100K Buy
997
+602
+152% +$60.6K 0.02% 294
2024
Q4
$35K Buy
395
+286
+262% +$25.2K 0.01% 386
2024
Q3
$9K Sell
109
-7,492
-99% -$591K ﹤0.01% 529
2024
Q2
$585K Buy
7,601
+28
+0.4% +$2.05K 0.09% 150
2024
Q1
$518K Buy
7,573
+47
+0.6% +$3.02K 0.08% 162
2023
Q4
$435K Buy
7,526
+170
+2% +$9.07K 0.07% 172
2023
Q3
$388K Buy
7,356
+85
+1% +$4.46K 0.07% 185
2023
Q2
$394K Buy
7,271
+7,149
+5,860% +$373K 0.07% 192
2023
Q1
$6K Hold
122
﹤0.01% 661
2022
Q4
$5K Hold
122
﹤0.01% 663
2022
Q3
$5K Buy
122
+23
+23% +$923 ﹤0.01% 670
2022
Q2
$4K Hold
99
﹤0.01% 683
2022
Q1
$4K Hold
99
﹤0.01% 707
2021
Q4
$4K Buy
99
+26
+36% +$1.09K ﹤0.01% 703
2021
Q3
$3K Hold
73
﹤0.01% 717
2021
Q2
$3K Hold
73
﹤0.01% 728
2021
Q1
$3K Hold
73
﹤0.01% 683
2020
Q4
$3K Hold
73
﹤0.01% 652
2020
Q3
$3K Hold
73
﹤0.01% 615
2020
Q2
$3K Hold
73
﹤0.01% 607
2020
Q1
$2K Hold
73
﹤0.01% 629
2019
Q4
$3K Hold
73
﹤0.01% 646
2019
Q3
$3K Hold
73
﹤0.01% 627
2019
Q2
$3K Hold
73
﹤0.01% 594
2019
Q1
$3K Hold
73
﹤0.01% 597
2018
Q4
$3K Hold
73
﹤0.01% 579
2018
Q3
$3K Hold
73
﹤0.01% 552
2018
Q2
$2K Buy
+73
New +$2.2K ﹤0.01% 549

Other funds holding BSX

Valley National Advisers's BSX Position: Q2 2026 in Review

Valley National Advisers reduced its Boston Scientific (BSX) stake by 89% in Q2 2026, selling an estimated $52K and leaving 123 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Valley National Advisers first reported a position in BSX in Q2 2018 and has held it in 33 quarters since. The position peaked at $585K in Q2 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Valley National Advisers held 123 shares of Boston Scientific worth $5.25K as of Q2 2026.
  • Valley National Advisers sold 957 Boston Scientific shares in Q2 2026, an estimated $52K.
  • Boston Scientific made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #711 holding.
  • Valley National Advisers first reported a position in Boston Scientific in Q2 2018 and has held it in 33 quarters since.
  • Valley National Advisers's Boston Scientific position peaked at $585K in Q2 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.